| Literature DB >> 15346337 |
Marianne Jauncey1, Joanne M Micallef, Stuart Gilmour, Janaki Amin, Peter A White, William Rawlinson, John M Kaldor, Ingrid van Beek, Gregory J Dore.
Abstract
A retrospective cohort of injection drug users with newly acquired hepatitis C virus (HCV) infection was established to examine viral clearance. Newly acquired HCV infection was defined by anti-HCV antibody seroconversion within a 2-year interval. Stored serum samples were tested for HCV RNA, with viral clearance defined as >/=2 consecutive negative HCV RNA test results after infection. Ninety-nine cases of HCV infection were identified; 57 had >/=2 HCV RNA test results after infection. Viral clearance occurred in 24 (42%) cases, with Kaplan-Meier estimated probabilities of 23%, 38%, and 40% at 6, 12, and 24 months, respectively.Entities:
Mesh：
Substances：
Year: 2004 PMID： 15346337 DOI： 10.1086/423943
Source DB: PubMed Journal: J Infect Dis ISSN： 0022-1899 Impact factor: 5.226